Switzerland· 67223005
Trimbow 87/5/9 mcg, solution pour inhalation en flacon pressurisé
A formoterol, glycopyrronium bromid und beclometason product containing beclometasoni dipropionas, formoteroli fumaras dihydricus, glycopyrronium, registered in Switzerland by Chiesi SA and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 10 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Formoterol, glycopyrronium bromid und beclometason is registered in 10 of 19 countries.
Countries holding a registration under ATC R03AL09 (formoterol, glycopyrronium bromid und beclometason), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 7 of them publish a price we can compare per daily dose
Formoterol, glycopyrronium bromid und beclometason · ATC R03AL09
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- beclometasoni dipropionas, formoteroli fumaras dihydricus, glycopyrronium
- Manufacturer
- Chiesi SA
- Country
- Switzerland (CH)
- ATC code
- R03AL09
- ATC class
- Formoterol, Glycopyrronium bromid und Beclometason
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680672230054360 DosCHF 192.7
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Formoterol, glycopyrronium bromid und beclometason in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandRiarifyChiesi Farmaceutici S.p.A.
- SpainTRIMBOW 172 microgramos/5 microgramos/9 microgramos SOLUCION PARA INHALACION EN ENVASE A PRESIONChiesi Farmaceutici S.P.A.
- IcelandTrimbowChiesi Farmaceutici S.p.A.*
- NetherlandsTrimbow 172 microgram/5 microgram/9 microgram aërosol, oplossingChiesi Farmaceutici S.p.A.
- IrelandTrydonis 87 micrograms/5 micrograms/9 micrograms pressurised inhalation, solutionChiesi Farmaceutici S.p.A.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f7389bbf-b1f6-4a42-a40c-e16d7850ee4f GET /v1/drugs/f7389bbf-b1f6-4a42-a40c-e16d7850ee4f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "beclometasoni dipropionas 87 mcg + formoteroli fumaras dihydricus 5 mcg + glycopyrronium 9 mcg",
"valid_from": "2020-08-01",
"limitations": "[{\"description\":\"<b>Chronisch obstruktive Lungenerkrankung (COPD)</b><br>\\nFür Patienten mit moderater COPD nach ≥ 1 moderaten Exazerbation pro Jahr trotz einer mindestens 3 Monate dauernder optimierter Therapie unter LABA/LAMA mit Eosinophilenzellzahl im Blut ≥ 100 Zellen/μl, welche nicht ausreichend eingestellt sind<br>\\noder<br>\\nfür Patienten mit moderater bis schwerer COPD nach ≥ 2 moderaten Exazerbationen pro Jahr oder ≥ 1 Exazerbation pro Jahr, welche zu einer Hospitalisation geführt hat trotz einer mindestens 3 Monaten dauernden optimierter Therapie unter ICS/LABA oder LABA/LAMA (für LABA/LAMA mit Eosinophilenzellzahl im Blut ≥ 100 Zellen/μl), welche nicht ausreichend eingestellt sind<br>\\noder<br>\\nfür Patienten mit COPD, welche bereits mit einer Kombination von LABA/LAMA und ICS oder ICS/LABA und LAMA mit mehreren Inhalatoren therapiert werden.<br>\\n<br>\\n\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2020-08-01\"}]",
"galenic_form": "Inhal Lös 87µg/5µg/9µg",
"therapeutic_area": null,
"sl_inclusion_date": "2020-08-01",
"self_retention_pct": 10
}See everything about formoterol, glycopyrronium bromid und beclometason.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.